 |
|
|
| |
Activity of danoprevir plus low-dose ritonavir in combination with peginterferon alfa-2a (40KD) plus ribavirin in previous null responders
|
| |
| |
Reported by Jules Levin EASL 2011 Berlin Germany March 31-April 3
R. Rouzier1, D. Larrey2, E.J. Gane3, A. Wiercinska-Drapalo4, L. Chang5,
Y. Zhang5, B. Gujral6, S. Le Pogam7, I. Nájera7, P. Smith7, N. Shulman5, J. Tran5
1Centre CAP; 2Saint Eloi Hospital, Montpellier, France; 3Auckland Clinical Studies,
Auckland, New Zealand; 4Medical University of Warsaw, Warszawa, Poland; 5Roche, South San Francisco, CA, USA; 6Roche, Welwyn, UK; 7Roche, Nutley, NJ, USA
|
| |
|
|
|
|
|
